跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 64,247 条关于
“T cell lymphoblastic lymphoma”
全部
64,247
临床试验
45,080
药物
5,998
机构
216
资讯
12,953
7个月前
FDA Approves Larger Vial Size of Nelarabine Injection for T-Cell Leukemia and Lymphoma Treatment
2年前
FDA Accepts NDA for SH-105, a Ready-to-Dilute Formulation for Breast and Ovarian Cancer
9个月前
Wugen's Allogeneic CAR-T Therapy Shows Promising Long-Term Survival Data in T-Cell Leukemia Patients
去年
Wugen Secures $115 Million to Advance First-in-Class Off-the-Shelf CAR-T Therapy for T-Cell Malignancies
去年
Universal CAR-T Cell Therapy Achieves 91% Response Rate in Aggressive T Cell Cancers
2个月前
Allotera Therapeutics Closes $35 Million Financing, Bringing Total to $150 Million for Pivotal-Stage Off-the-Shelf CAR-T Therapy in T-Cell Cancers
2年前
WU-CART-007 Shows Promise in Relapsed/Refractory T-ALL/LBL
去年
Wugen Initiates Pivotal Trial of Novel Off-the-Shelf CAR-T Therapy for Rare Blood Cancers
去年
FDA Clears IND for Bioheng's Off-the-Shelf CAR-T Therapy CTD402 for T-Cell Leukemia/Lymphoma
前天
Tempest Therapeutics Secures Exclusive Option to Senlang's CD7-Targeted Lentiviral In Vivo CAR-T Platform and BCMA/GPRC5D Candidate
第 1 页，共 1296 页
上一页
下一页
